Emory Vaccine Center - The Hope Clinic

Decatur, Georgia 30030-2517

0 studies enrolling now · 21 studies all time

What they study most

Avian Influenza, COVID-19, Clostridial Infection, Cytomegalovirus Infection, Dysbiosis, Gastroenteritis Norovirus, Influenza, Influenza Immunisation, Pneumococcal Infection, Probiotic Therapy, Smallpox, Tuberculosis

Studies at this site

• ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 — Completed
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) — Stopped early
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• 2013/2017 H7N9 Prime-Boost Interval — Completed
• Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally — Completed
• Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS) — Stopped early
• Challenge Model for Assessment of Human TB Immunity — Completed
• Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies — Completed
• Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers — Completed
• H7N9 Mix and Match With MF59 in Healthy Elderly Persons — Completed
• A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine — Completed
• H7N9 Mix and Match With MF59 in Healthy Adults — Completed
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® — Completed
• Phase II Tularemia Vaccine Comparison — Completed
• Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations — Completed
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations — Completed
• H5N1 Mix and Match With MF59 — Completed
• Sanofi H1N1 + TIV - Adults and Elderly — Completed